Marinomed Biotech Ag

Nicox S.a.

Marinomed Biotechnologie Gmbh

Visufarma B.v.

Christiane Koller

Andreas Grassauer

Eva Prieschl-Grassauer

Alexander Pretsch

Frédéric Pilotaz

Angelika Bodenteich

Martina Morokutti-Kurz

Sabine Nakowitsch

Marielle König-Schuster

Frederic Pilotaz

Martina Morokutti-kurz

Eva Prieschl-grassauer

Marielle Konig-Schuster

Marielle KÖNIG-Schuster

A pharmaceutical composition has a stuffy nose deblocking activity. The composition includes a hyperosmolar aqueous solution of a non-ionic osmolality adjusting agent, optionally in combination with an ionic osmolality adjusting agent, wherein the composition further includes iota-carrageenan and/or kappa-carrageenan as an active antiviral ingredient in an antivirally effective amount, with the proviso that the composition in its ready-for-use formulation contains no more than 0-1.5% w/v of the ionic osmolality adjusting agent. The composition is useful for deblocking a stuffy nose and for prophylactic or therapeutic intervention of a number of viral infections of the upper respiratory tract.

Stuffy nose deblocking composition having antiviral activity

Disclosed herein is a method of reducing the risk of a rhinovirus infection, the method includes administering to a subject a composition comprising iota-carrageenan in an antiviral effective amount as an active antiviral ingredient.

Antiviral composition and method of use

The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is substantially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.

Composition effective against viral conjunctivitis

A method for manufacturing an antiviral pharmaceutical composition for the prophylaxis or treatment of a rhinovirus infection that includes the utilization of iota-, kappa- or lambda-carrageenan or mixtures thereof.

Growing community of inventors

Seyring, Austria

Christiane Koller